切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2016, Vol. 05 ›› Issue (03) : 195 -197. doi: 10.3877/cma.j.issn.2095-3232.2016.03.016

所属专题: 文献

综述

microRNA-122在肝脏疾病中的作用
黄思敏1, 黎福良2, 车斯尧2,()   
  1. 1. 524000 湛江,广东医学院研究生学院
    2. 525200 广东,高州市人民医院肝胆外科
  • 收稿日期:2016-03-14 出版日期:2016-06-10
  • 通信作者: 车斯尧

Role of microRNA-122 in liver diseases

Simin Huang1, Fuliang Li2, Siyao Che2()   

  • Received:2016-03-14 Published:2016-06-10
  • Corresponding author: Siyao Che
引用本文:

黄思敏, 黎福良, 车斯尧. microRNA-122在肝脏疾病中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2016, 05(03): 195-197.

Simin Huang, Fuliang Li, Siyao Che. Role of microRNA-122 in liver diseases[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2016, 05(03): 195-197.

关键词: RNA, 肝, 治疗学
[1]
Song YX, Yue ZY, Wang ZN, et al. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation[J]. Mol cancer, 2011(10): 1.
[2]
Song KH, Li T, Owsley E, et al. A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes[J]. J Lipid Res, 2010, 51(8): 2223-2233.
[3]
Luna JM, Scheel TK, Danino T, et al. Hepatitis C virus RNA functionally sequesters miR-122[J]. Cell, 2015, 160(6): 1099-1110.
[4]
Jopling CL, Yi M, Lancaster AM, et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA[J]. Science, 2005, 309(5740): 1577-1581.
[5]
Jopling CL, Schutz S, Sarnow P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome[J]. Cell Host Microbe, 2008, 4(1): 77-85.
[6]
Thibault PA, Huys A, Amador-Cañizares Y, et al. Regulation of hepatitis C virus genome replication by Xrn1 and microRNA-122 binding to individual sites in the 5' untranslated region[J]. J Virol, 2015, 89(12): 6294-6311.
[7]
Pang PS, Pham EA, Elazar M, et al. Structural map of a microRNA-122: hepatitis C virus complex[J]. J Virol, 2012, 86(2): 1250-1254.
[8]
Machlin ES, Sarnow P, Sagan SM. Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex[J]. Proc Natl Acad Sci U S A, 2011, 108(8): 3193-3198.
[9]
Shimakami T, Yamane D, Jangra RK, et al. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex[J]. Proc Natl Acad Sci U S A, 2012, 109(3): 941-946.
[10]
Roberts AP, Doidge R, Tarr AW, et al. The P body protein LSm1 contributes to stimulation of hepatitis C virus translation, but not replication, by microRNA-122[J]. Nucleic Acids Res, 2014, 42(2): 1257-1269.
[11]
Kumar S, Chawla YK, Ghosh S, et al. Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patients sera[J]. Dis Markers, 2014: 435476.
[12]
Shibata C, Ohno M, Otsuka M, et al. The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels[J]. Virology, 2014(462/463): 42-48.
[13]
Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA[J]. N Engl J Med, 2013, 368(18): 1685-1694.
[14]
Chen Y, Shen A, Rider PJ, et al. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication[J]. FASEB J, 2011, 25(12): 4511-4521.
[15]
Wang S, Qiu L, Yan X, et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity[J]. Hepatology, 2012, 55(3): 730-741.
[16]
Qiu L, Fan H, Jin W, et al. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV[J]. Biochem Biophys Res Commun, 2010, 398(4): 771-777.
[17]
Hsu SH, Wang B, Kota J, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver[J]. J Clin Invest, 2012, 122(8): 2871-2883.
[18]
Tsai WC, Hsu SD, Hsu CS, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis[J]. J Clin Invest, 2012, 122(8): 2884-2897.
[19]
Bai S, Nasser MW, Wang B, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib[J]. J Biol Chem, 2009, 284(46): 32015-32027.
[20]
Fornari F, Gramantieri L, Giovannini C, et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells[J]. Cancer Res, 2009, 69(14): 5761-5767.
[21]
Wu Q, Liu HO, Liu YD, et al. Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity[J]. J Biol Chem, 2015, 290(2): 1170-1185.
[22]
Lin CJ, Gong HY, Tseng HC, et al. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines[J]. Biochem Biophys Res Commun, 2008, 375(3): 315-320.
[23]
Wong CC, Au SL, Tse AP, et al. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis[J]. PloS one, 2014, 9(12): e115036.
[24]
Wang B, Hsu SH, Wang X, et al. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2[J]. Hepatology, 2014, 59(2): 555-566.
[25]
Spaniel C, Honda M, Selitsky SR, et al. microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection[J]. PloS one, 2013, 8(10): e76867.
[1] 郝玥萦, 毛盈譞, 张羽, 汪佳旭, 韩林霖, 匡雯雯, 孟瑶, 杨秀华. 超声引导衰减参数成像评估肝脂肪变性及其对心血管疾病风险的预测价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 770-777.
[2] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[7] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[8] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[9] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
[10] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[11] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[12] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[13] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[14] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[15] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?